[HTML][HTML] Post-COVID-19 Achalasia?
FS Mohammed, N Krogel - Digestive Diseases and Sciences, 2023 - Springer
This letter is concerning the article regarding post-COVID-19 gastrointestinal dysmotility [1].
While SARS-CoV-2-induced ACE-2 depletion and neuronal tropism may cause motility …
While SARS-CoV-2-induced ACE-2 depletion and neuronal tropism may cause motility …
A132 achalasia following a SARS-CoV-2 infection: a case report
E Zeidan, E Desilets, M Bouin… - Journal of the Canadian …, 2022 - academic.oup.com
Background SARS-CoV-2 is a novel virus currently causing a major pandemic. Recent
studies have shown that SARS-CoV-2 has an affinity to ACE2 receptors which are present in …
studies have shown that SARS-CoV-2 has an affinity to ACE2 receptors which are present in …
S2266 Achalasia as a Sequelae of COVID-19
Discussion: Sars-Cov-2 enters the GI epithelial cells through ACE2 receptors and exerts its
effects through an aberrant immune response involving T-lymphocytes rather than direct …
effects through an aberrant immune response involving T-lymphocytes rather than direct …
[HTML][HTML] Acute-onset achalasia following a recent covid-19 infection: a case report
AU Wasim, MW Khan, OA Khan, KS Almatraf - Cureus, 2023 - ncbi.nlm.nih.gov
Achalasia is a rare esophageal motility disorder that leads to dysphagia, regurgitation, and
several other symptoms. While the etiology of achalasia is not completely understood …
several other symptoms. While the etiology of achalasia is not completely understood …
Is the Sars‐CoV‐2 virus a possible trigger agent for the development of achalasia?
J Furuzawa‐Carballeda… - …, 2023 - Wiley Online Library
Background Achalasia is an autoimmune disease whose probable causal agent is a
neurotropic virus that chronically infects the myenteric plexus of the esophagus and induces …
neurotropic virus that chronically infects the myenteric plexus of the esophagus and induces …
Rapid development of achalasia after SARS-CoV-2 infection: PCR analysis of esophageal muscle tissue
S Samo, F Hamo, A Hamza, R Yadlapati… - Official journal of the …, 2022 - journals.lww.com
Methods: We aimed to prospectively evaluate esophageal muscle for SARS-CoV-2 from
patients with rapid-onset achalasia post-COVID-19 and compare them to achalasia …
patients with rapid-onset achalasia post-COVID-19 and compare them to achalasia …
[PDF][PDF] Long COVID-19 and achalasia: a possible relationship
R Aponte, N Daulabani, R Parra… - Int J Community Med …, 2022 - academia.edu
Achalasia is a rare esophageal motor disorder with a worldwide prevalence of around 10
cases per 100 000 inhabitants, and an incidence of one new case per 100 000 inhabitants …
cases per 100 000 inhabitants, and an incidence of one new case per 100 000 inhabitants …
[PDF][PDF] Infection with SARS-CoV-2 as a potential achalasia trigger
PR Zafra, CJG Sánchez, AP Ramírez, AG Soto… - Rev Esp Enferm …, 2023 - online.reed.es
Discussion Within the hypothetical viral etiology of idiopathic achalasia, SARS-CoV-2 might
be thought of as a potential triggering agent. Other case reports in the literature seemingly …
be thought of as a potential triggering agent. Other case reports in the literature seemingly …
[HTML][HTML] Perception of the COVID-19 pandemic in patients with achalasia and its impact on gastrointestinal symptoms: a proof-of-concept study
Background Currently, no data are available on COVID-19 pandemic perception in patients
with achalasia. We evaluated how the COVID-19 lockdown was perceived by these patients …
with achalasia. We evaluated how the COVID-19 lockdown was perceived by these patients …
An unexpected thoracic finding in a patient with COVID-19
A Calì, RF La Fortezza, P Fusaroli - Gastroenterology, 2021 - gastrojournal.org
Achalasia is an uncommon esophageal motility disorder, usually characterized by
dysphagia to solids and liquids, chest pain, regurgitation, and weight loss. High-resolution …
dysphagia to solids and liquids, chest pain, regurgitation, and weight loss. High-resolution …